Nous avons trouvé 3 résultat(s).
Certains éléments peuvent ne pas apparaître en raison des règles de confidentialité.
Certains éléments peuvent ne pas apparaître en raison des règles de confidentialité.
Aucun enregistrement trouvé.
Veuillez mettre à jour vos critères de recherche et essayer à nouveau
Veuillez mettre à jour vos critères de recherche et essayer à nouveau
Like its US and European counterparts, the World Vaccine Congress India will bring together leading in-country vaccine manufacturers, including Serum Institute of India, Biological E, Shantha, Cipla, ...
Like its US and European counterparts, the World Vaccine Congress India will bring together leading in-country vaccine manufacturers, including Serum Institute of India, Biological E, Shantha, Cipla, CPL, Bharat, Haffkine, Panacea, Zydus Cadila and more.
Besides talking about the latest technologies in process innovation and therapeutics, Serum Institute and Biological E’s public business model approach will be weighed against the private business model approach, and the current pricing discussions being held globally will also be brought to fore.
Held alongside Biopharma India, the World Vaccine Congress India will be a combination of case study presentations, panel discussions and focus-group discussions across two days. As with our US and Europe events, there will be ample networking opportunities for you to cement existing relationships and develop lucrative new partnerships.
Besides talking about the latest technologies in process innovation and therapeutics, Serum Institute and Biological E’s public business model approach will be weighed against the private business model approach, and the current pricing discussions being held globally will also be brought to fore.
Held alongside Biopharma India, the World Vaccine Congress India will be a combination of case study presentations, panel discussions and focus-group discussions across two days. As with our US and Europe events, there will be ample networking opportunities for you to cement existing relationships and develop lucrative new partnerships.
Vaccines 2017 conference features highly enlightening and interactive sessions to encourage the exchange of ideas across a wide range of disciplines in the field of vaccination and therapeutics. The c...
Vaccines 2017 conference features highly enlightening and interactive sessions to encourage the exchange of ideas across a wide range of disciplines in the field of vaccination and therapeutics. The conference includes explicit keynote talks from distinguished scientists, plenary sessions, Poster competition, Young Researcher sessions, Symposiums, Workshop and Exhibitions.
Topics Covered in the conference:
Live, attenuated vaccines, Inactivated vaccines, Subunit vaccines, Toxoid vaccines, Conjugate vaccines, DNA vaccines, Recombinant vector vaccines, Inactivated/Killed Vaccines, Experimental Vaccines, Valence Vaccines, Heterotypic Vaccines, monovalent/ univalent/ multivalent/polyvalent Vaccines, innovative vaccines, inactivated (killed antigen), subunit (purified antigen), Toxins (inactivated Toxins), recombinant subunit vaccine, Developing immunity, Trends in Vaccine Development, History of Vaccines, Effectiveness of Vaccines, History of Vaccines Development, Expectations Towards Safety of Vaccines, vaccine preventable diseases, vaccine safety in immunization programmes, vaccine regulations, pre-licensure vaccine safety, post-licensure vaccine safety, balancing vaccines efficacy and safety, Vaccines Pharmacovigilance, Vaccines of the Future, Vaccinia (smallpox), Measles, mumps, rubella (MMR combined vaccine), Varicella (chickenpox) vaccine, Influenza (nasal spray), Rotavirus, Herpes Zoster (shingles) vaccine, etc.
Topics Covered in the conference:
Live, attenuated vaccines, Inactivated vaccines, Subunit vaccines, Toxoid vaccines, Conjugate vaccines, DNA vaccines, Recombinant vector vaccines, Inactivated/Killed Vaccines, Experimental Vaccines, Valence Vaccines, Heterotypic Vaccines, monovalent/ univalent/ multivalent/polyvalent Vaccines, innovative vaccines, inactivated (killed antigen), subunit (purified antigen), Toxins (inactivated Toxins), recombinant subunit vaccine, Developing immunity, Trends in Vaccine Development, History of Vaccines, Effectiveness of Vaccines, History of Vaccines Development, Expectations Towards Safety of Vaccines, vaccine preventable diseases, vaccine safety in immunization programmes, vaccine regulations, pre-licensure vaccine safety, post-licensure vaccine safety, balancing vaccines efficacy and safety, Vaccines Pharmacovigilance, Vaccines of the Future, Vaccinia (smallpox), Measles, mumps, rubella (MMR combined vaccine), Varicella (chickenpox) vaccine, Influenza (nasal spray), Rotavirus, Herpes Zoster (shingles) vaccine, etc.
Theme: A New Era in Vaccines research & Development. Topics: Recombinant vector vaccines, Subunit vaccines, conjugate Vaccines, Inactivated/Killed Vaccines, Experimental Vaccines, Valence Vaccines, He...
Theme: A New Era in Vaccines research & Development. Topics: Recombinant vector vaccines, Subunit vaccines, conjugate Vaccines, Inactivated/Killed Vaccines, Experimental Vaccines, Valence Vaccines, Heterotypic Vaccines, monovalent/ univalent/ multivalent/polyvalent Vaccines, innovative vaccines, inactivated (killed antigen), subunit (purified antigen), Toxins (inactivated Toxins), recombinant subunit vaccine, Developing immunity, Trends in Vaccine Development, History of Vaccines, Effectiveness of Vaccines, History of Vaccines Development, Expectations Towards Safety of Vaccines, vaccine preventable diseases, vaccine safety in immunization programmes, vaccine regulations, pre-licensure vaccine safety, post-licensure vaccine safety, balancing vaccines efficacy and safety, etc.